Towards Healthcare
Pulse Oximeter Market Size Booms 6.64% CAGR by 2034

Pulse Oximeter Market Growth and Regional Production Analysis

According to forecasts, the global pulse oximeter market will grow from USD 3.56 billion in 2024 to USD 6.76 billion by 2034, with an expected CAGR of 6.64%. The rising cases of respiratory and cardiovascular illness, along with the rise in home healthcare and remote patient monitoring. Technological advancement and integration with wearables further boost market growth.

Category: Healthcare Services Insight Code: 5581 Format: PDF / PPT / Excel

Deepa Pandey

Principal Consultant

Aditi Shivarkar

Reviewed By

Pulse Oximeter Market Size, Strategic Analysis & Growth Opportunities

The global pulse oximeter market size is calculated at USD 3.56 billion in 2024, grow to USD 3.8 billion in 2025, and is projected to reach around USD 6.76 billion by 2034.

Pulse Oximeter Market Size 2024 - 2034

Key Takeaways

  • North America dominated the global pulse oximeter market in 2024.
  • Asia-Pacific is anticipated to grow at the highest CAGR in the market during the forecast period.
  • By component, the monitors segment held a dominant presence in the market in 2024.
  • By component, the sensor segment is anticipated to grow at the fastest rate in the market during the studied years.
  • By type, the tabletop/bedside pulse oximeter segment was dominant in the market in 2024.
  • By type, the portable pulse oximeter segment is expected to grow at the fastest rate in the coming years.
  • By age group, the adult segment held the highest share of the market in 2024.
  • By age group, the pediatric segment is estimated to grow at a significant rate during the predicted timeframe.
  • By end-use, the hospital segment held the largest share of the market.
  • By end-use, the home care segment is predicted to grow at the fastest CAGR in the pulse oximeter market.

Key Metrics and Overview

Metric Details
Market Size in 2024 USD 3.56 Billion
Projected Market Size in 2034 USD 6.76 Billion
CAGR (2025 - 2034) 6.64%
Leading Region North America
Market Segmentation By Component, By Type, By Age Group, By End Use, By Region 
Top Key Players

Smiths Group plc., Halmaplc, Koninklijke Philips N.V., Medtronic plc, Nihon Kohden Corporation, Masimo Corporation, Contec Medical Systems Co., Ltd., Omron Healthcare, Inc., General Electric Company, Nonin Medical, Inc. 

Pulse Oximeter: Outsourcing Expertise

A pulse oximeter is a non-invasive medical device that measures the oxygen saturation level (SpO2) of your blood and your pulse rate. It is commonly used in hospitals, clinics, and at home to monitor respiratory conditions. The market is growing due to the increasing prevalence of respiratory and cardiovascular diseases, especially among the aging population. As per the 2023 insights from the World Heart Federation, cardiovascular diseases affect more than 500 million people across the globe. These conditions are responsible for around 20.5 million deaths each year, accounting for nearly one-third of the total global mortality.

Technological advancements such as wireless connectivity and improved accuracy have made these devices more efficient and user-friendly. The rise in health awareness and fitness tracking has also boosted demand among consumers. Additionally, expanding healthcare infrastructure in emerging markets is creating new opportunities for manufacturing, further contributing to the steady growth of the global market.

  • In May 2024, Masimo teamed up with Medable Inc. to bring medical-grade wearable devices into the field of clinical research. As part of this collaboration, Medable included Masimo’s MightySat Rx pulse oximeter in its evidence-generation platform, supporting eight major pharmaceutical clinical trials. These studies, which span across 25 countries and involve more than 3,000 patients, are centered on two types of cancer: breast cancer and lung cancer.
  • In April 2024, Nonin formed a partnership with Medixine to create remote digital monitoring solutions aimed at improving patient-focused diagnosis of chronic conditions. This collaboration combines Medixine’s digital platform for remote patient monitoring with Nonin’s pulse oximetry devices, targeting the U.S. market.

How Can AI Revolutionize the Pulse Oximeter Market?

AI has the potential to revolutionize the market by enhancing both device functionality and patient care. By leveraging advanced data analytics, AI can process oxygen saturation and pulse rate data in real-time, identifying patterns and early indicators of health issues like respiratory or cardiac problems. AI also enables personalized health monitoring, adjusting to individual baselines and providing accurate, customized alerts. Additionally, AI supports remote patient monitoring by automatically notifying healthcare providers about critical health changes, improving proactive care. With predictive capabilities, AI can forecast potential complications and assist in early intervention for chronic conditions like COPD. Integration with other wearables and health apps creates a more comprehensive health profile, while in clinical settings, AI aids clinicians in making faster, more informed decisions and optimizing patient care.

Market Dynamics

Driver

Increasing Incidence of Respiratory Diseases

In respiratory conditions, the growing need for continuous monitoring of oxygen levels in patients is a major driver for the pulse oximeter market. Diseases like chronic obstructive pulmonary disease (COPD), asthma, and pneumonia require regular oxygen saturation monitoring to assess the severity of the condition and ensure the proper treatment. Pulse oximeters are essential tools in providing non-invasive, real-time measurement of blood oxygen levels. As the prevalence of respiratory diseases rises, in both developed and developing regions, the demand for pulse oximeters in hospitals, clinics, and home care settings increases. Early detection of low oxygen levels helps manage these conditions more effectively, thereby driving market growth.

Restraint

Government Regulations

Government regulation acts as a restraint due to stringent approval and compliance processes that manufacturers must follow. Regulatory bodies like the FDA (U.S. Food and Drug Administration)  require extensive clinical testing, certification, and safety evaluation before pulse oximeters can be sold, which can delay time-to-market. Additionally, varying regulations across different regions can complicate the manufacturing and distribution process for global companies. Compliance with these regulations often involves significant costs and resources, which can limit the entry of new players into the pulse oximeter market and hinder innovation.

Opportunity

Remote Patient Monitoring and Telemedicine

As the healthcare system shifts towards more patient-centered, home-based care, pulse oximeters can play a key role in enabling conditions monitoring of patients with chronic conditions like asthma, COPD, and heart failure, especially in remote and underserved areas. Integration with mobile apps and wearable devices offers real-time data sharing with healthcare providers, enhancing early detection and timely intervention. Additionally, the increasing adoption of wearable health technologies and growing awareness of health monitoring present a significant growth opportunity for pulse oximeters in both clinical and home healthcare settings.

Segmental Insights

The Monitors Segment Dominated

By component, the monitors segment held a dominant presence in the market in 2024. The dominance is attributed to the critical role of the monitors in providing continuous and accurate monitoring of blood oxygen saturation and pulse rate, essential in both clinical and home settings. Technological advancements, such as the integration of Organic Light-Emitting Diode (OLED), Liquid Crystal Display (LCD), and High-Definition (HD) displays, have enhanced the functional and user experience of pulse oximeter monitors. For instance, in July 2024, Santa Medical introduced its premium OLED SM-1100 Silver Finger Pulse Oximeter, Generation2, featuring strong battery performance, highlighting the trend towards more advanced and user-friendly devices.

The Sensor Segment: Fastest Growing

By component, the sensor segment is anticipated to grow at the fastest rate in the market during the studied years. Sensors are crucial in providing accurate and reliable oxygen saturation (SpO2) measurements, which are essential for diagnosing respiratory conditions and monitoring patients in various healthcare settings. Advancements in sensor technology, such as the development of more precise and durable sensors, are driving this growth. Additionally, the increasing demand for wearable health devices and the shift towards home-based healthcare are further contributing to the expansion of the pulse oximeter market.

The Tabletop/Bedside Pulse Oximeter Segment Dominated

By type, the tabletop/bedside pulse oximeter segment was dominant in the market in 2024. The widespread integration in hospitals and healthcare facilities, including intensive care units, surgical theaters, and emergency departments. These devices offer continuous, real-time monitoring of oxygen saturation and pulse rate, essential for critically ill patients. Their larger displays, audible alarms, and integration with patient monitoring systems enhance their effectiveness in clinical settings. Additionally, advancements in technology, such as improved sensor accuracy and connectivity features, have further solidified their presence among healthcare professionals.

The Portable Pulse Oximeter Segment: Fastest-Growing

By type, the portable pulse oximeter segment is expected to grow at the fastest rate in the coming years, due to rising demand for home-based healthcare and greater health awareness among consumers. These compact devices respiratory conditions or elderly patients to monitor their oxygen levels conveniently at home, reducing the need for frequent clinical visits. Technological advancements, such as Bluetooth connectivity, smartphone integration, and longer battery life, have made portable oximeters more user-friendly and reliable. Additionally, the growing focus on preventive health monitoring and the ease of real-time data sharing with healthcare providers further drive the adoption of portable pulse oximeters.

The Adult Segment: Highest Shares

By age group, the adult segment held the highest share of the market in 2024, driven by the increasing prevalence of chronic respiratory and cardiovascular diseases among adults. Conditions such as chronic obstructive pulmonary disease (COPD) and asthma are more common in this age group, necessitating regular monitoring of oxygen levels. For instance, the American Lung Association reported that approximately 1.7 million adults, or 4.6% of the adult population, were diagnosed with COPD, including conditions like chronic bronchitis or emphysema. Additionally, the growing geriatric population further contributes to the demand for the pulse oximeter market.

The Pediatric Segment: Significantly Growing

By age group, the pediatric segment is estimated to grow at a significant rate during the predicted timeframe, due to the rising incidence of respiratory conditions in children, such as asthma, bronchiolitis, and pneumonia. With millions of children affected by these conditions globally, there is an increasing need for reliable, non-invasive monitoring tools. Technological advancements have led to the development of smaller, more accurate pediatric pulse oximeters with user-friendly features, making them ideal for both clinical and home use. Additionally, the growing trend towards home-based healthcare has driven the adoption of these devices among parents and caregivers, further boosting demand and accelerating the growth of the pulse oximeter market.

The Hospital Segment: Largest Shares

By end-use, the hospital segment held the largest share of the market. The extensive use of pulse oximeters in hospitals for continuous monitoring of patients' oxygen saturation levels and pulse rates. These devices are essential in critical care environments, including intensive care units (ICUs), emergency departments, surgical units, and postoperative recovery rooms. The high patient volume and the need for real-time, accurate monitoring in these settings drive the significant demand for pulse oximeters in hospitals. Additionally, advancement in pulse oximeter technology, such as improved sensor accuracy and integration with hospital monitoring systems, have further solidified their role in hospital settings, contributing to the expansion of the market.

The Home Care Segment: Fastest Growing

By end-use, the home care segment is predicted to grow at the fastest CAGR in the pulse oximeter market, due to the rising prevalence of chronic respiratory diseases like COPD and asthma, which require regular monitoring of oxygen levels. Pulse oximeters offer a convenient, non-invasive way for patients to manage their health from the comfort of their homes. Technological advancements have made these devices more user-friendly and effective for remote monitoring. Additionally, the aging population, which is more vulnerable to respiratory conditions, is driving the need for accessible home-based healthcare solutions. As more people prefer at-home care for its convenience and cost-efficiency, the demand for portable, easy-to-use pulse oximeters is increasing market growth.

In January 2023, Philips and Masimo strengthened their partnership by integrating the Masimo W1 health watch into Philips’s monitoring system, enhancing remote patient monitoring and telehealth services.

High Prevalence of Chronic Respiratory Conditions Drives North America

North America dominated the global pulse oximeter market in 2024. The region has a high prevalence of chronic respiratory conditions like COPD and sleep apnea, which require continuous monitoring of oxygen levels. Additionally, North America benefits from a well-developed healthcare infrastructure and early adoption of advanced medical technologies, making pulse oximeters widely accessible in clinical and home settings. The growing geriatric population further drives demand, as older adults are more prone to respiratory and cardiovascular issues. Moreover, ongoing technological advancements such as improved sensor accuracy and integration with digital health platforms have strengthened the adoption of pulse oximeters across the region, solidifying market expansion.

The U.S. Pulse Oximeter Market Trends

The U.S. market is growing due to the rising prevalence of chronic respiratory conditions like COPD and asthma, which increase the demand for oxygen monitoring. Technological advancements and mobile app integration have made pulse oximeters more accessible, and the rise of telehealth services also contributes to the market growth. Additionally, heightened awareness further drove adoption, establishing pulse oximeters as essential tools for home and clinical healthcare. In March 2024, Movano Health, in collaboration with UCSF, completed a hypoxia trial, showing that its Evie Ring pulse oximeter exceeds U.S. FDA accuracy guidelines, emphasizing the influence of academic research on product development.

The Canada Pulse Oximeter Market Trends

The Canadian market is expanding due to growing technological innovation, supportive government regulations, and increasing public awareness. Advancements such as wireless connectivity, smartphone integration, and cloud-based data storage have made pulse oximeters more efficient and user-friendly, encouraging their use in both clinical and home settings. Regulatory backing from Health Canada has also helped build trust in device reliability and safety. Additionally, awareness campaigns highlighting the importance of monitoring blood oxygen levels have led more Canadians to adopt oximeters for early detection of respiratory conditions, driving market growth.

Respiratory Disorders Cause by Different Viruses 2024, (%)

The Large Population Propels Asia-Pacific

Asia-Pacific is anticipated to grow at the highest CAGR in the market during the forecast period. The region's large and aging population, rising prevalence of respiratory and cardiovascular diseases, rising prevalence of respiratory and cardiovascular diseases, and increasing health awareness are major drivers. Improvement in healthcare infrastructure, growing investment in telemedicine, and expanding home healthcare services are also fueling demand. Additionally, rising disposable income and government initiatives supporting early disease detection contribute to market growth.

The China Pulse Oximeter Market Trends

The market is growing rapidly due to a combination of healthcare, demographic, and technological factors. China’s large and aging population is increasingly affected by chronic conditions like COPD, asthma, and cardiovascular diseases, driving demand for regular oxygen monitoring. The government is also heavily investing in expanding and modernizing healthcare infrastructure, especially in rural and underserved areas. Additionally, the rise of telemedicine and home healthcare services, along with growing health awareness among the public, has led to increased adoption of portable medical devices.

The India Pulse Oximeter Market Trends

The Market in India is expanding due to the country’s increasing focus on digital health and self-monitoring tools. With the growth of the tech-savvy population, more people are adopting health gadgets for preventive care. India’s booming start-up ecosystem has also played a role, with local manufacturing offering affordable and innovative pulse oximeters tailored to domestic needs. Additionally, the Indian government’s push for “Make In India” has encouraged local production, reducing costs and improving accessibility. The expansion of private healthcare facilities and diagnostics labs is further supporting the market growth.

Increasing Shift Towards Personalized and Preventive Healthcare

Europe is anticipated to grow at the fastest CAGR in the market during the forecast period, due to an increasing shift towards personalized and preventive healthcare. The region is witnessing a surge in demand for wearable and connected health devices, driven by the popularity of fitness and wellness trends. Additionally, growing investment in digital health technologies and integration of pulse oximeters with telehealth platforms are fueling adoption. Strict regulatory standards in Europe have also led to the development and availability of high-quality, accurate devices, boosting consumer confidence. Moreover, rising healthcare expenditure and expanding reimbursement coverage are making these devices more accessible to a wider population.

The UK Pulse Oximeter Market Trends

The market is expanding due to a combination of rising health challenges and proactive healthcare initiatives. The increasing prevalence of chronic respiratory conditions such as COPD, sleep apnea, and heart diseases has created a growing need for continuous oxygen monitoring. The UK government has also taken significant steps to address racial and ethnic disparities in medical devices, including pulse oximeters, which has increased public trust and market demand.  Additionally, the growing adoption of home healthcare and remote patient monitoring, supported by technological advancements like smartphone connectivity and wearable integration, has made pulse oximeters more accessible and appealing to a wider population.

The Germany Pulse Oximeter Market Trends

The German market is growing due to its strong healthcare infrastructure, high healthcare spendings, and a large aging population that require regular monitoring of vital signs. The prevalence of chronic diseases, such as cardiovascular and respiratory disorders, is also contributing to increased demand for pulse oximeters. Furthermore, Germany has a strong focus on preventive healthcare, encouraging the use of personal health monitoring devices. The integration of advanced technologies and data tracking in pulse oximeters is appealing to tech-savvy consumers and healthcare providers alike, supporting the continued growth of the market.

Top Companies in the Pulse Oximeter Market

Pulse Oximeter Market Companies

Latest Announcement by Industry Leaders

  • In August 2024, Prevounce Health launched the Pylo OX1-LTE, a blood oxygen device for remote patient monitoring (RPM). It’s designed to help patients with chronic respiratory conditions like COPD and asthma, as well as those with COVID-19 or heart conditions. Daniel Tashnek, CEO of Prevounce, stated, "The OX1-LTE couldn’t be simpler for patients to use, boosting RPM program engagement and reducing clinician and technical support work, helping scale remote monitoring programs." This device aims to improve ease of use and participation in RPM initiatives.

Recent Developments in the Pulse Oximeter Market

  • In January 2025, the United States Food and Drug Administration released guidelines for manufacturers regarding the calibration of their devices to better read pulse oxygen readings for people of color, by ensuring devices are tested across a variety of skin tones. The new guidelines ask companies to mandate the collection of 3,000 data points rather than 200. Studies conducted using these meters will also need to be composed of a minimum of 10 people, with 150 being the recommended sample size.
  • In November 2023, Masimo teamed up with GE Healthcare to combine Masimo's Signal Extraction Technology (SET) pulse oximetry with GE’s Portrait Mobile, a wearable and wireless patient monitoring system. This collaboration enables healthcare providers to use Masimo’s advanced technology, which accurately measures oxygen levels even during patient movement or low blood flow. The integration supports continuous, noninvasive SpO2 monitoring, helping clinicians track and respond to changes in a patient’s condition more efficiently.

Segments Covered in the Report

By Component

  • Monitors
  • Sensors

By Type

  • Portable Pulse Oximeter
    • Fingertip Pulse Oximeter
    • Handheld Pulse Oximeter
  • Wearable Pulse Oximeter
    • Tabletop/bedside Pulse Oximeter

By Age Group

  • Adult
  • Pediatric

By End Use

  • Hospitals
  • Home Care
  • Outpatient Facilities
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • Last Updated: 28 April 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Deepa Pandey is a healthcare market research expert with 2+ years of experience, specializing in analyzing market trends, regulatory impacts, and emerging opportunities to guide strategic decision-making in the healthcare sector.

Learn more about Deepa Pandey

Aditi Shivarkar, with over 14 years of experience in consumer goods, leads research at Towards Consumer Goods, ensuring precise, actionable insights on trends, consumer preferences, and sustainable packaging for businesses.

Learn more about Aditi Shivarkar

Related Reports

FAQ's

A normal SpO2 reading usually ranges from 95% to 100%. Anything below 90% is considered low or may require medical attention.

Medical-grade devices are FDA-approved and often provide more consistent readings, especially in critical care.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, National Medical Products Administration.